South Africa is about to start the first clinical trial of a new crown vaccine in Africa
Xinhua News Agency, Johannesburg, June 23 (Reporter Jing Jing) Jinshan University, South Africa announced on the 23rd online press conference that South Africa will start the first clinical trial of the new continent vaccine on the African continent from this week.
The vaccine used in the trial was developed by the Jenner Institute of Oxford University in the UK and is currently undergoing clinical trials in the UK.
Sabir Mady, a professor of vaccines at Jinshan University who is in charge of trials in South Africa, said that the new crown epidemic has reached the current stage, and clinical trials of vaccines are of great significance to South Africa and the whole of Africa. South Africa has entered the winter, and public hospitals are under pressure Increasingly, "we need a new crown vaccine more than ever."
Jinshan University said that there are currently more than 100 new crown vaccines under development worldwide, and some vaccine research institutions in South Africa will participate in the development and testing of multiple vaccines.
As of 22nd, the number of confirmed cases of new crowns in Africa has exceeded 300,000, and the number of confirmed cases in South Africa has exceeded 100,000.